Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling
S Russ Price1, Jennifer L Gooch, Sue K Donaldson
1Renal Division, School of Medicine, Emory University, Atlanta, Georgia 30322, USA. russ.price@emory.edu
Abstract:
Muscle atrophy is a significant consequence of chronic kidney disease that increases a patient's risk of mortality and decreases their quality of life. The loss of lean body mass results, in part, from an increase in the rate of muscle protein degradation. In this review, the proteolytic systems that are activated during chronic kidney disease and the key insulin signaling pathways that regulate the protein degradative processes are described.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Type II Diabetes II: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology

